About
DarioHealth is a global digital therapeutics company aiming to revolutionize how people with chronic conditions manage their health, with offerings that include highly rated diabetes and hypertension solutions. The companys AI-powered digital therapeutic solutions are designed to do more than simply support an individuals disease. Dario provides adaptive, personalized experiences that drive behavior change through evidence-based interventions, high-quality software, coaching, and intuitive, clinically proven digital tools to help individuals improve their health and sustain meaningful outcomes. DarioHealth operates at the intersection of life sciences, behavioral science, and software technology and is rapidly expanding into new chronic conditions and geographic markets using a performance-based approach to improve its users health.
Funding history · 15 rounds · $244.6M total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- When did DarioHealth go public on NASDAQ?
- DarioHealth went public on NASDAQ in February 2013.
- What was DarioHealth's former name?
- DarioHealth was formerly known as LabStyle Innovations.
- What was the total amount raised by DarioHealth through funding rounds?
- DarioHealth has raised a total of $244,607,600 through various funding rounds. For a full financing history, please refer to startupim.
- Which investor participated in DarioHealth's $50 million Debt Financing round in June 2022?
- OrbiMed was an investor in DarioHealth's $50 million Debt Financing round in June 2022.
- What was the value of DarioHealth's acquisition in February 2024?
- DarioHealth completed an acquisition valued at $30,000,000 in February 2024.
- When did DarioHealth acquire Twill, and what was the strategic goal?
- DarioHealth acquired Twill in February 2024, aiming to create one of the most comprehensive digital health platforms across prevalent chronic conditions.
- What was the purpose of DarioHealth's strategic reorganization in June 2024?
- In June 2024, DarioHealth announced a strategic reorganization to empower commercial expansion and appointed an inaugural Chief Commercial Officer.
- What was the outcome of DarioHealth's Q4 2024 earnings report regarding revenue growth?
- DarioHealth reported a 32.9% increase in full-year 2024 revenue, reaching $27.0 million from $20.4 million in 2023, driven by B2B2C channel growth including employers and health plans.
- What new offering did DarioHealth expand in January 2025?
- In January 2025, DarioHealth expanded its GLP-1 solution with prescribing capabilities through a collaboration with MediOrbis, targeting employers and direct-to-consumer markets.